The Oswaldo Cruz Foundation is a scientific institution for research and development in biological sciences located in Rio de Janeiro, Brazil; it is considered one of the world's main public health research institutions. It was founded by Dr. Oswaldo Cruz, a noted physician and epidemiologist.

During the past decade, Fundacao Oswaldo Cruz conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacao Oswaldo Cruz" #1 sponsor was "Oswaldo Cruz Foundation" with 6 trials, followed by "University of Heidelberg Medical Center" with 3 trials sponsored, "Janssen Vaccines & Prevention B.V." with 2 trials sponsored, "Cynthia S Firnhaber" with 1 trials sponsored and "Global Alliance for TB Drug Development" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacao Oswaldo Cruz" #1 collaborator was "University of Sao Paulo" with 4 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 2 trials as a collaborator, "European Union" with 2 trials as a collaborator, "Oswaldo Cruz Foundation" with 2 trials as a collaborator and "Rio de Janeiro State Research Supporting Foundation (FAPERJ)" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Fundacao Oswaldo Cruz" are "Zika Virus" (2 trials), "COVID-19" (1 trials), "Cutaneous Leishmaniasis" (1 trials), "Dengue" (1 trials) and "Dengue Fever" (1 trials). Many other conditions were trialed in "Fundacao Oswaldo Cruz" in a lesser frequency.

Most popular intervention types in "Fundacao Oswaldo Cruz" are "Drug" (7 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Meglumine antimoniate" (2 trials), "Ad26.COV2.S" (1 trials), "Ad26.Mos4.HIV" (1 trials) and "BCG (Bacillus Calmette-Guérin) vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacao Oswaldo Cruz" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Fundacao Oswaldo Cruz". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Fundacao Oswaldo Cruz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacao Oswaldo Cruz, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".